2000
DOI: 10.1055/s-0037-1614162
|View full text |Cite
|
Sign up to set email alerts
|

Identification of Type 2 von Willebrand Disease in Previously Diagnosed Type 1 Patients: a Reappraisal Using Phenotypes, Genotypes and Molecular Modelling

Abstract: SummaryIn order to investigate the possibility that qualitative type 2 defects in von Willebrand factor (VWF) occurred in patients previously diagnosed with quantitative type 1 von Willebrand disease (VWD), the phenotypes and genotypes were reanalysed in 30 patients who exhibited discrepant VWF activity/VWF:Ag ratios of less than 0.7. The capacity of VWF to bind to glycoprotein Ib (GpIb) was reassessed using the ristocetin co-factor activity (VWF:RiCo) assay compared to an in-house and a commercial ELISA assay… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
74
0
1

Year Published

2002
2002
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 54 publications
(76 citation statements)
references
References 29 publications
1
74
0
1
Order By: Relevance
“…In addition to the physiological fragmentation of the subunit, the mutated VWF shows the presence of an additional 209-kDa species not observed in normal type 1, 2A, 2B, and 2N VWF (52). The relative loss of large (Table 5) (48,51,53). The laboratory phenotype of the R1315C mutation is characterized by subnormal values for FVIII:C (mean 41 U/dL), low levels for VWF:Ag (mean 20 U/dL), very low or undetectable levels for VWF:RCo of less than 0.10 U/dL, and a decreased VWF:RCo/Ag ratio.…”
Section: Autosomal Dominant Vwd Type 2mmentioning
confidence: 88%
See 1 more Smart Citation
“…In addition to the physiological fragmentation of the subunit, the mutated VWF shows the presence of an additional 209-kDa species not observed in normal type 1, 2A, 2B, and 2N VWF (52). The relative loss of large (Table 5) (48,51,53). The laboratory phenotype of the R1315C mutation is characterized by subnormal values for FVIII:C (mean 41 U/dL), low levels for VWF:Ag (mean 20 U/dL), very low or undetectable levels for VWF:RCo of less than 0.10 U/dL, and a decreased VWF:RCo/Ag ratio.…”
Section: Autosomal Dominant Vwd Type 2mmentioning
confidence: 88%
“…There is no consensus about the definition of "normal high molecular weight" multimers. Three of the 2M VWD patients showed a quantitative loss of the highest VWF multimers in two studies (46,47) (Table 3), whereas a normal VWF multimeric pattern has been noted in the other 19 2M patients (45)(46)(47)(48) (Table 3). RIPA was not measured in 14, but was uniformly decreased or absent in 8, which constitutes a very characteristic feature of VWD 2M (45)(46)(47)(48) (Table 3).…”
Section: Autosomal Dominant Vwd Type 2mmentioning
confidence: 97%
“…16 On the other hand, there is the distinct possibility that these patients with low VWF:RCo/Ag ratio, decreased ristocetin-induced platelet agglutination, and normal or near normal multimeric structure are carriers of a qualitatively abnormal VWF protein in its interaction with platelets and that they should be classified as having type 2M VWD, as recently suggested. [17][18][19] This hypothesis can be only validated by the knowledge of gene defects and by the demonstration that the expressed recombinant proteins have abnormal reactions with platelet membrane glycoproteins. In the absence of these molecular data, the 8 patients with low VWF:RCo/Ag ratios were still kept in the type 1 VWD group, as originally indicated by the participating centers at the time of enrollment.…”
Section: Discussionmentioning
confidence: 99%
“…Considering that the complete absence of HMW multimers is required for type 2A, Casonato et al [16] and Nitu-Walley et al [4] recommend the inclusion of R1374C in subtype 2M VWD. The reason for this is that some HMWM of VWF are present in this variant, with multimers even larger than those seen in normal VWF.…”
Section: Discussionmentioning
confidence: 99%